| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Innovation Officer | VP Peripheral Nerve Science | VP Of Clin. &Trans. Sciences +1 more
1 company
Devinney Erick Wayne is a Chief Innovation Officer at Axogen, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $10.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | AXGN Axogen, Inc. | Chief Innovation Officer | Sell | 19,517 | $31.21 | $609,086.54 | -7.5% | -4.3% | - | |
| Sep 16, 2025 | AXGN Axogen, Inc. | Chief Innovation Officer | Sell | 1,137 | $16.29 | $18,521.73 | -0.5% | +78.0% | - | |
| Mar 19, 2025 | AXGN Axogen, Inc. | Chief Innovation Officer | Sale+OE | 15,111 | $17.50 | $264,442.50 | -6.5% | -46.8% | +74.1% | |
| Mar 21, 2024 | AXGN Axogen, Inc. | Chief Innovation Officer | Sale+OE | 4,578 | $7.68 | $35,159.04 | -0.9% | -11.2% | +131.0% | |
| Dec 29, 2020 | AXGN Axogen, Inc. | VP, Clinical&Translational Sc | Sell | 371 | $17.81 | $6,607.51 | -0.6% | - | - | |
| Dec 21, 2020 | AXGN Axogen, Inc. | VP, Clinical&Translational Sc | Sell | 147 | $16.42 | $2,413.74 | -0.2% | - | - |